Abbott Laboratories
LSE:0Q15
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
LSE:0Q15
|
US |
|
Baidu Inc
LSE:0HL1
|
CN |
|
P
|
Pfizer Inc
SWB:PFE
|
US |
|
Holcim AG
OTC:HCMLF
|
CH |
Wall St Price Targets
0Q15 Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for 0Q15 is 121.61 USD with a low forecast of 93.56 USD and a high forecast of 143.79 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0Q15's stock price target?
Price Target
121.61
USD
According to Wall Street analysts, the average 1-year price target for 0Q15 is 121.61 USD with a low forecast of 93.56 USD and a high forecast of 143.79 USD.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.
